NO995711D0 - Kinolin-4-karboksamid-derivater som NK-2 og NK-3-reseptorantagonister - Google Patents
Kinolin-4-karboksamid-derivater som NK-2 og NK-3-reseptorantagonisterInfo
- Publication number
- NO995711D0 NO995711D0 NO995711A NO995711A NO995711D0 NO 995711 D0 NO995711 D0 NO 995711D0 NO 995711 A NO995711 A NO 995711A NO 995711 A NO995711 A NO 995711A NO 995711 D0 NO995711 D0 NO 995711D0
- Authority
- NO
- Norway
- Prior art keywords
- quinoline
- receptor antagonists
- carboxamide derivatives
- carboxamide
- derivatives
- Prior art date
Links
- 108010040722 Neurokinin-2 Receptors Proteins 0.000 title 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title 1
- 102100029409 Neuromedin-K receptor Human genes 0.000 title 1
- 102100037342 Substance-K receptor Human genes 0.000 title 1
- LEWDKQKVAFOMPI-UHFFFAOYSA-N quinoline-4-carboxamide Chemical class C1=CC=C2C(C(=O)N)=CC=NC2=C1 LEWDKQKVAFOMPI-UHFFFAOYSA-N 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9710750.2A GB9710750D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
| IT002354 IT1295358B1 (it) | 1997-10-17 | 1997-10-17 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
| ITMI972775 IT1296976B1 (it) | 1997-12-16 | 1997-12-16 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
| PCT/EP1998/003014 WO1998052942A1 (en) | 1997-05-23 | 1998-05-18 | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995711D0 true NO995711D0 (no) | 1999-11-22 |
| NO995711L NO995711L (no) | 2000-01-19 |
Family
ID=27268859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995711A NO995711L (no) | 1997-05-23 | 1999-11-22 | Kinolin-4-karboksamid-derivater som NK-2 og NK-3- reseptorantagonister |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0983262B1 (no) |
| JP (1) | JP2002500645A (no) |
| CN (1) | CN1264378A (no) |
| AP (1) | AP9901695A0 (no) |
| AR (1) | AR012732A1 (no) |
| AT (1) | ATE244711T1 (no) |
| AU (1) | AU8209898A (no) |
| BG (1) | BG104009A (no) |
| BR (1) | BR9809652A (no) |
| CA (1) | CA2291111A1 (no) |
| CO (1) | CO4950515A1 (no) |
| DE (1) | DE69816290T2 (no) |
| DZ (1) | DZ2498A1 (no) |
| EA (1) | EA199901062A1 (no) |
| ES (1) | ES2201509T3 (no) |
| HU (1) | HUP0002300A3 (no) |
| ID (1) | ID22876A (no) |
| IL (1) | IL133036A0 (no) |
| MA (1) | MA26501A1 (no) |
| NO (1) | NO995711L (no) |
| OA (1) | OA11515A (no) |
| PE (1) | PE75199A1 (no) |
| PL (1) | PL336942A1 (no) |
| SK (1) | SK159299A3 (no) |
| TR (1) | TR199902883T2 (no) |
| WO (1) | WO1998052942A1 (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9825554D0 (en) * | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
| US6780875B2 (en) * | 1998-11-20 | 2004-08-24 | Smithkline Beecham S.P.A. | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| EP1131295A1 (en) * | 1998-11-20 | 2001-09-12 | Smithkline Beecham S.p.A. | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| EP1165542B1 (en) | 1999-03-29 | 2003-08-20 | Neurogen Corporation | 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
| AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
| AU2001276556A1 (en) * | 2000-08-11 | 2002-02-25 | Smithkline Beecham P.L.C. | Novel pharmaceutical use of quinnoline derivatives |
| WO2002038547A1 (en) * | 2000-11-13 | 2002-05-16 | Glaxosmithkline Spa | Quinoline derivatives as nk-3 and nk-2 antagonists |
| WO2002044165A1 (en) * | 2000-11-28 | 2002-06-06 | Glaxosmithkline Spa | Quinoline derivatives as nk-3 antagonists |
| GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
| US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
| GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
| JP2004525184A (ja) * | 2001-04-11 | 2004-08-19 | グラクソスミスクライン・ソシエタ・ペル・アチオニ | Nk−3およびnk−2受容体アンタゴニストとしての3−置換キノリン−4−カルボキサミド誘導体 |
| MY134211A (en) * | 2001-05-18 | 2007-11-30 | Smithkline Beecham Corp | Novel use |
| GB0425076D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0425075D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
| CN101189211A (zh) * | 2005-06-03 | 2008-05-28 | 阿斯利康(瑞典)有限公司 | 作为nk3拮抗剂的喹啉衍生物 |
| GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
| AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
| DE202007017299U1 (de) * | 2007-12-12 | 2009-04-23 | Drebo Werkzeugfabrik Gmbh | Bohrer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2227769T3 (es) * | 1994-05-27 | 2005-04-01 | Glaxosmithkline S.P.A. | Derivados de quinolina como antagonistas del receptor nk3 de taquiquinina. |
| AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
-
1998
- 1998-05-18 CN CN98807356A patent/CN1264378A/zh active Pending
- 1998-05-18 CA CA002291111A patent/CA2291111A1/en not_active Abandoned
- 1998-05-18 HU HU0002300A patent/HUP0002300A3/hu unknown
- 1998-05-18 BR BR9809652-4A patent/BR9809652A/pt not_active IP Right Cessation
- 1998-05-18 IL IL13303698A patent/IL133036A0/xx unknown
- 1998-05-18 EA EA199901062A patent/EA199901062A1/ru unknown
- 1998-05-18 AP APAP/P/1999/001695A patent/AP9901695A0/en unknown
- 1998-05-18 AT AT98932069T patent/ATE244711T1/de not_active IP Right Cessation
- 1998-05-18 SK SK1592-99A patent/SK159299A3/sk unknown
- 1998-05-18 TR TR1999/02883T patent/TR199902883T2/xx unknown
- 1998-05-18 ID IDW991432A patent/ID22876A/id unknown
- 1998-05-18 EP EP98932069A patent/EP0983262B1/en not_active Expired - Lifetime
- 1998-05-18 DE DE69816290T patent/DE69816290T2/de not_active Expired - Fee Related
- 1998-05-18 ES ES98932069T patent/ES2201509T3/es not_active Expired - Lifetime
- 1998-05-18 AU AU82098/98A patent/AU8209898A/en not_active Abandoned
- 1998-05-18 JP JP54996798A patent/JP2002500645A/ja not_active Ceased
- 1998-05-18 PL PL98336942A patent/PL336942A1/xx unknown
- 1998-05-18 WO PCT/EP1998/003014 patent/WO1998052942A1/en not_active Ceased
- 1998-05-19 DZ DZ980108A patent/DZ2498A1/xx active
- 1998-05-20 PE PE1998000398A patent/PE75199A1/es not_active Application Discontinuation
- 1998-05-21 AR ARP980102363A patent/AR012732A1/es not_active Application Discontinuation
- 1998-05-21 MA MA25086A patent/MA26501A1/fr unknown
- 1998-05-22 CO CO98029024A patent/CO4950515A1/es unknown
-
1999
- 1999-11-22 NO NO995711A patent/NO995711L/no not_active Application Discontinuation
- 1999-11-23 OA OA9900253A patent/OA11515A/en unknown
- 1999-12-14 BG BG104009A patent/BG104009A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199902883T2 (xx) | 2000-05-22 |
| DE69816290D1 (de) | 2003-08-14 |
| SK159299A3 (en) | 2000-06-12 |
| AU8209898A (en) | 1998-12-11 |
| BR9809652A (pt) | 2001-09-11 |
| WO1998052942A1 (en) | 1998-11-26 |
| MA26501A1 (fr) | 2004-12-20 |
| DZ2498A1 (fr) | 2003-01-25 |
| ES2201509T3 (es) | 2004-03-16 |
| HUP0002300A2 (hu) | 2001-06-28 |
| NO995711L (no) | 2000-01-19 |
| OA11515A (en) | 2004-02-04 |
| DE69816290T2 (de) | 2004-05-27 |
| EA199901062A1 (ru) | 2000-08-28 |
| BG104009A (en) | 2000-07-31 |
| ATE244711T1 (de) | 2003-07-15 |
| ID22876A (id) | 1999-12-16 |
| AP9901695A0 (en) | 1999-12-31 |
| PE75199A1 (es) | 1999-10-22 |
| EP0983262B1 (en) | 2003-07-09 |
| PL336942A1 (en) | 2000-07-17 |
| AR012732A1 (es) | 2000-11-08 |
| JP2002500645A (ja) | 2002-01-08 |
| IL133036A0 (en) | 2001-03-19 |
| CO4950515A1 (es) | 2000-09-01 |
| EP0983262A1 (en) | 2000-03-08 |
| HUP0002300A3 (en) | 2002-01-28 |
| CA2291111A1 (en) | 1998-11-26 |
| CN1264378A (zh) | 2000-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012473L (no) | Kinolin-4-karboksamidderivater som NK-3 og NK-2 reseptorantagonister | |
| NO995711D0 (no) | Kinolin-4-karboksamid-derivater som NK-2 og NK-3-reseptorantagonister | |
| NO982333L (no) | Kinolinkarboksamid-derivater, deres fremstilling og deres anvendelse som Neurokinin 3 (NK-3)- og Neurokinin 2 (NK-2) reseptorantagonister | |
| NO965036L (no) | Kinolinderivater som techykinin NK3 reseptor-antagonister | |
| NO20013809D0 (no) | Indolderivater og anvendelse derav som MCP-1 antagonister | |
| NO20032797L (no) | Substituerte pyridoindoler som serotonin agonister og antagonister | |
| DK1035115T3 (da) | 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister | |
| DK0901470T3 (da) | Indolderivater egnede som endothelinreceptorantagonister | |
| ID19623A (id) | Antagonis reseptor vitronektin | |
| FI19992312L (fi) | Laite palon sammuttamiseksi | |
| DK0922034T3 (da) | Tetrahydroquinolinderivater som EAA-antagonister | |
| NO996115D0 (no) | Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister | |
| NO990786L (no) | Acylaminoalkenylen-amidderivater som NK1 og NK2 antagonister | |
| DK1216250T3 (da) | Thienoisoxazolyl- og thienylpyrazolyl-phenoxy- substituerede propylderivater som D4-antagonister | |
| NO20026103D0 (no) | 1-amino-alkylcycloheksaner som 5-HT3 og neuronal nikotinreseptorantagonister | |
| AU2002215043A1 (en) | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists | |
| NO963331D0 (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| DE69703242D1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten | |
| NO994679D0 (no) | Quinolin-2-karboksylsyrederivat og anvendelse derav som eksitatorisk aminosyreantagonist | |
| DE69717449D1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten | |
| NO20011779D0 (no) | Ureidopiperidinderivater som selektive humane NK3 reseptor antagonister | |
| HK1028236A (en) | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists | |
| AU2002310838A1 (en) | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists | |
| NO20021249D0 (no) | Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater som D4antagonister | |
| AU2002308138A1 (en) | 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |